Skip to main content
Caplight Logo









Axiom Bio

Axiom Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.axi.om/

Last Round

M&A

Nov 11, 2015

Total Funding Raised

$23.2M

Company Overview

Axiom Bio is a biotechnology company that provides AI-driven predictive models to assess molecular toxicity in drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

toxicity predictiondrug discoveryin silicopredictive modelingclinical risk assessmentAI drug discoveryADMEdrug safetybiological modelingAI reasoning agentanimal testing alternativesData as a ServiceDaaSbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axiom Bio Comparables

Compare Axiom Bio with similar companies based on industry and business-model similarity.

Axiom Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Quris AI
83%
VeriSIM Life
81%
PredictCan Biotechnologies
81%

Axiom Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&ANov 11, 2015
GrantOct 8, 2013
Series AOct 8, 2013
SeedDec 24, 2012
DebtNov 7, 2012

Key People

Founding team and executive leadership

Brandon White

Co-Founder, CEO

Founding Team

Axiom Bio Investors

Notable investors and investment history

Axiom Bio investors
InvestorRounds
Connecticut InnovationsSeed, Series A
NIH RADxGrant
Zetta Venture PartnersSeed
Elm Street VenturesSeed, Series A
Amplify PartnersSeed
DimensionSeed
Vital Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Grew 18% QoQ, from 22 to 26 employees.

  • Feb 20, 2026

    Grew 37% QoQ, from 19 to 26 employees.

Axiom Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Axiom Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axiom Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range25
Year Founded2024
Last FundingNov 11, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?